US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 81.855
  • +0.945+1.17%
Trading Apr 29 09:39 ET
15.54BMarket Cap77.22P/E (TTM)

Biomarin Pharmaceutical Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 26, 2024

Based on 23 analysts giving stock ratings to Biomarin Pharmaceutical in the past 3 months

Buy

  • Buy

    73.91%

  • Hold

    26.09%

  • Sell

    0.00%

Price Target

Updated: Apr 26, 2024

The average Biomarin Pharmaceutical stock price target is 111.05 with a max estimate of 140.00 and a min estimate of 80.00

Review Biomarin Pharmaceutical earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 26, 2024

Buy

  • Buy

    73.91%

  • Hold

    26.09%

  • Sell

    0.00%

Price Target

Updated: Apr 26, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg